Infant Bacterial Therapeutics AB (publ) (IBT-B.ST) - Stock Prices, Stock Peers & Analysis

Home
IBT-B.ST

Company Name	Infant Bacterial Therapeutics AB (publ)
Symbol	IBT-B.ST
Currency	SEK
Price	93.4
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	1,215,890,540
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	41.3 - 106.5
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Staffan Stromberg Ph.D.
Website	https://www.ibtherapeutics.com

An error occurred while fetching data.

About Infant Bacterial Therapeutics AB (publ)

Infant Bacterial Therapeutics AB (publ), a clinical stage pharmaceutical company, develops drugs to prevent or treat rare diseases affecting premature infants in Sweden. The company's lead drug candidate is IBP-9414, to prevent necrotizing enterocolitis, as well as to improve feeding tolerance affecting premature infants. It is also developing IBP-1016 for